Volume : 10, Issue : 11, November – 2023

Title:

REVIEW ON “BIPOLAR PERSONALITY DISORDER”

Authors :

Dipti D. Damodar, Mr. V. D Rathod, Aniket P. Sawasakade, Pallavi P. Atalkar, Sejal R. Sahu, Dhiraj A. Thaddani, Tejas G. Niwane

Abstract :

Persistent mental illness, bipolar disorder affects more than 1% of people worldwide. It causes a person’s mood and energy to shift abruptly, and it also impairs their capacity to think rationally. Neurotransmitter imbalance, along with genetic and environmental factors, are the main causes of bipolar disorder. Diabetes, cardiovascular disease, and metabolic syndrome are more likely in people with bipolar disorder. In the medical world, early diagnosis is uncommon since bipolar disorder lacks biomarkers and is characterized by nonspecific symptoms or a rapid shift in mood. Suicide risk is heightened by depression, which is the major factor.
Approximately 20 times more people commit suicide owing to bipolar disorder than the overall population, according to an SMR survey. Both nonpsychiatric and psychiatric medical specialists should be present at the same time. Lithium is reportedly frequently prescribed to lower the risk of suicide. A patient with bipolar disorder may have a wide range of symptoms, including stress, hypomania, and mania. Additionally, it has been observed that patients and their families are reluctant and unable to comprehend the significance of symptoms, particularly those of hypomania or mania. The main issue is that no study or research on bipolar disorder has been able to live. The severe to find the exact or correct treatment for bipolar disorder, leading to a treatment that is lifelong and involves a combination of medications and psychotherapy. There is also an urgent need for the right and perfect medication to treat this problem. Early diagnosis and treatment.
KEYWORDS: Stress, Suicide, Mania, Depression, Disability, and Hypomania are all symptoms of bipolar illness

Cite This Article:

Please cite this article in press Dipti D. Damodar et al, Review On Bipolar Personality Disorder., Indo Am. J. P. Sci, 2023; 10 (11).

Number of Downloads : 10

References:

1. Bebbington P, Ramana R. The epidemiology of bipolar affective disorder. Soc Psychiatry Psychiatr Epidemiol (1995); 30:279-292.
2. Weissman MM, Leaf PJ, Tischler GL, et al. Affective disorders in five United States communities. Psychol med (1988); 18:141-153
3 Weissman MM, Bruce ML, Leaf PJ, et al: Affective disorders, in Psychiatric Disorders in America. Edited by Robins L, Regier DA. New York, Free Press, (1990)
4. Weissman MM, Leaf PJ, Tischer GL, et al: Affective disorders in five United States communities. Psychological Medicine 18: 141–153, (1988)
5. National survey of NDMDA members finds long delay in diagnosis of manic-depressive illness. Hospital and Community Psychiatry 44:800–802,(1993)
6. Greenberg PE, Stiglin LE, Finkelstein SN, et al: The economic burden of depression in 1990. Journal of Clinical Psychiatry 54:405–418,(1993)
7. Keck PE, Bennett JA, Stanton SP:” Economic aspects of the treatment of manic-depression illness with hDivalproex”Review of Contemporary Pharmacotherapy6:597–604, (1995)
8. Goodwin FK, Jamison KR: “Manic-Depressive Illness”. New York, Oxford University Press, (1990)
9. Reus VI, Freimer NB:” Understanding the genetic basis of mood disorders”: where do we stand? American Journal of Human Genetics 60:1283–1288, (1997)
10. Altshuler LL, Curran JG, Hauser P, et al: “T2 hyperintensities in bipolar disorder: “Magnetic resonance imaging comparison and literature meta-analysis. American Journal of Psychiatry 152:1139–1144, (1995)
11. Post RM, Rubinow DR, Ballenger JC: “Conditioning, sensitization, and kindling: implications for the course of affective illness,” in The Neurobiology of Mood Disorders. Edited by Post RM, Ballenger JC. Baltimore, Williams & Wilkins, (1984 )
12. “Diagnostic and Statistical Manual of Mental Disorders”, 4th ed. Washington, DC, American Psychiatric Association, (1994)
13. Hirschfeld RM, Cass AR, Holt DC, Carlson CA. “Screening for bipolar disorder in patients treated for depression in a family medicine clinic”. J Am Board Fam Pract. (2005);18(4):233-239.
14. Goldberg JF, Garno JL, Callahan AM, et al. “Overdiagnosis of bipolar disorder among substance use disorder in patients with mood instability.” J Clin Psychiatry. (2008);69(11):1751-1757.
15. Zimmerman M, Ruggero CJ, Chelminski I, Young D. Is bipolar disorder overdiagnosed? J Clin Psychiatry.( 2008);69(6):935-940.
16. Hirschfeld RM, Lewis L, Vornik LA. “Perceptions and impact of bipolar disorder: how far have we come? results of the national depressive and manic-depressive” Association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. (2003);64(2):161-174.
17. Zimmerman M, Ruggero CJ, Chelminski I, Young D. Psychiatric diagnoses in patients previously overdiagnosed with bipolar disorder. J Clin Psychiatry. (2010);71(1):26-31.
18. Vieta E, Valenti M. Mixed states in DSM-5: “Implications for clinical care, education, and research.”J Affect Disord.( 2013);148(1):28-36.
19. Angst J, Cui L, Swendsen J, et al. “Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication”. Am J Psychiatry. (2010);167(10):1194-1201.
20. McIntyre RS, Lee Y, Mansur RB. “A pragmatic approach to the diagnosis and treatment of mixed features in adults with mood disorders.” CNS Spectr. (2016);21(S1):25-33.
21. Mitchell PB, Goodwin GM, Johnson GF, Hirschfeld RM. “Diagnostic guidelines for bipolar depression: a probabilistic approach”. Bipolar Disord. (2008);10(1 pt 2):144-152.
22. Akiskal HS. “The dark side of bipolarity: detecting bipolar depression in its pleomorphic expressions.” J Affect Disord. (2005);84(2-3):107-115.
23. Othmer E, Desouza CM, Penick EC, et al. Indicator 23. Callaghan RC, Veldhuizen S, Jeysingh T, et al. “Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression”. J Psychiatr Res. (2014);48(1):102-110.
23. Kleinman L, Lowin A, Flood E, et al. “Costs of bipolar disorder”. Pharmacoeconomics. ( 2003);21(9):601-622.
25. Dean BB, Gerner D, Gerner RH. “A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder.” Curr Med ReaAs Opin. (2004);20(2):139-154.
26. Ostachear MJ, Nierenberg AA, Iosifescu DV, et al. “Correlates of subjective and objective burden among caregivers of patients with bipolar disorder”. Acta Psychiatr Scand. (2008);118(1):49-56.
27. Stensland MD, Jacobson JG, Nyhuis A. Service utilization and associated direct costs for bipolar disorder in 2004: “An analysis in managed care.” J Affect Disord. (2007);101(1-3):187-193.
28. Goldberg JF, Garno JL, Harrow M.” Long-term remission and recovery in bipolar disorder”
29. Sachs GS, Nierenberg AA, Calabrese JR, et al. “Effectiveness of adjunctive antidepressant treatment for bipolar depression.” N Engl J Med. (2007);356(17):1711-1722. r: a review. Curr Psychiatry Rep.( 2005);7(6):456-461.
30. Culpepper L. “Misdiagnosis of bipolar depression in primary care practices”. J Clin Psychiatry. 2014;75(3):e05. http://www. psychiatrist.com/jcp/article/Pages/2014/v75n03/v75n03e05. aspx. Accessed on June 17,( 2017).
31. Berk M, Dodd S, Berk L, Opie J.” Diagnosis and management of patients with bipolar disorder in primary care”. Br J Gen Pract.( 2005);55(518):662-664.
89. Hirschfeld RM, Cass AR, Holt DC, Carlson CA. “Screening for bipolar disorder in patients treated for depression in a family medicine clinic”. J Am Board Fam Pract. 2005;18(4):233-239.
32. Goldberg JF, Garno JL, Callahan AM, et al. “Overdiagnosis of bipolar disorder among substance use disorder in patients with mood instability”. J Clin Psychiatry. (2008);69(11):1751-1757.
33. Zimmerman M, Ruggero CJ, Chelminski I, Young D. I”s bipolar disorder overdiagnosed”? J Clin Psychiatry. (2008);69(6):935-940.
34. JR Geddes., et al. “Long-Term Lithium Therapy for Bipolar Disorder: Systematic Review and Meta-Analysis of Randomized Controlled Trials”. American Journal of Psychiatry 161.2 (2004): 247-222.
35. LV Kessing., et al. “Valproate v. lithium in the treatment of bipolar disorder in clinical practice: Observational nationwide register-based cohort study”. British Journal of Psychiatry (2011): 57-63.
36. S Derry and RA Andrew. “Atypical antipsychotics in bipolar disorder: Systematic review of randomized trials”. BMC Psychiatry 7 (2007): 40.
37. KD Chang. “The use of atypical antipsychotics in pediatric bipolar disorder”. Journal of Clinical Psychiatry 4 (2008): 4-8.
38.T Suppes., et al. “Effectiveness of the extended-release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression”. Journal of Affective Disorders (2010): 485-493.
39. ME Thase., et al. “Efficacy of quetiapine monotherapy in bipolar I and II depression: A double-blind, placebo-controlled study (the BOLDER II study)”. Journal of Clinical Psychopharmacology 26.6 (2006): 600-609.
40. E Vieta., et al. “Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: A meta-analysis of randomized controlled trials”. The International Journal of Neuropsychopharmacology 14.8 (2011): 1029-1049.
41. CL Bowden and V Singh. “Valproate in bipolar disorder: 2000 Onwards”. Acta Psychiatrica Scandinavica 426 (2005): 13-20
42. I Pacchiarotti., et al. “The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders”. The American Journal of Psychiatry 170.11 (2013): 1249-1262.
43. L Tondo., et al. “Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders”. Acta Psychiatrica Scandinavica 127.5 (2013): 355-364.
44. G Vázquez., et al. “Comparison of antidepressant responses in patients with bipolar vs. unipolar depression: A meta-analytic review”. Pharmacopsychiatry 44.1 (2011): 21-26.
45. BH Amit and A Weizman. “Antidepressant treatment for acute bipolar depression: An update”. Depression Research and Treatment (2012): 684725.
111. KR Connolly and ME Thase. “The clinical management of bipolar disorder: A review of evidence-based guidelines”. The Primary Care Companion to The Journal of Clinical Psychiatry (2011): 10r01097.
46. U Mccormick., et al. “Diagnosis and treatment of patients with bipolar disorder: A review for advanced practice nurses”. Journal of the American Association of Nurse Practitioners 27.9 (2015): 530-542.
47. VP Kamboj. “Herbal medicine”. Current Science 78.1 (2000): 35-39.S Bent and R Ko. “Commonly used herbal medicines in the United States: A review”. American Journal of Medicine 116.7 (2004): 478- 485.
48. NJ Gogtay., et al. “The use and safety of non-allopathic Indian medicines”. Drug Safety 25.14 (2002): 1005-1019.
49. V Gupta., et al. “Therapeutic efficacy of Phytochemicals as anti-anxiety-a review”. Journal of Pharmacy Research (2010).
50. Center for Substance Abuse Treatment. “Managing depressive symptoms in substance abuse clients during early recovery”. Substance Abuse and Mental Health Services Administration. (2008) http://store.samhsa.gov/shin/content/SMA12-4353/TIP48.pdf. Accessed April 23, (2013). [Google Scholar]